Synopsis: Five stocks in which ace investor Mukul Agarwal holds a stake witnessed FII ownership rise by up to 4.5 percent in Q3FY26, signalling growing foreign investor confidence alongside strong promoter holding.
Foreign Institutional Investor (FII) stake serves as a powerful indicator of global confidence in a company and the broader market. Rising FII ownership often reflects strong fundamentals, growth visibility, and governance standards, while declining holdings may signal caution. Tracking FII trends helps investors gauge sentiment, liquidity flows, and emerging investment opportunities.
Ace investor Mukul Agarwal is a renowned Indian market participant known for his sharp stock-picking skills in small and mid-cap stocks. With decades of experience and a long-term value investing approach, he is known as the Warren Buffett of India, he focuses on fundamentally strong, scalable businesses. As per his Q3FY26 holdings, he owns 72 stocks with a net worth exceeding Rs 6,766 crore. Following are the ace investor stocks where FIIs have increased their holding in Q3FY26.
Hindustan Construction Company Ltd
Hindustan Construction Company Ltd, incorporated in 1926, is a leading Indian engineering and construction company specializing in infrastructure development. Headquartered in Mumbai, it executes complex projects across transportation, water, power, and industrial sectors, delivering iconic landmarks including highways, metro rail systems, dams, tunnels, and hydroelectric power projects.
In Q3FY26 Hindustan Construction Company Ltd has seen its revenue from operations decrease by 8 percent YoY, from Rs 1007 Cr in Q3FY25 to Rs 925 Cr in Q3FY26, while the QoQ also decreased by 4 percent from Rs 961 Cr. The company made a net loss of Rs 39 Cr in Q3FY25, which has now turned around to become a net profit of Rs 8 Cr in Q3FY26.
December 2025 , Mukul Agrawal, holds more than 4 Crore equity shares, equivalent to 1.7 percent in the company. While, the Foreign institutional investors (FIIs) have increased their stake by 0.83 percent in December 2025, rising from 9.58 percent in Sept 2025 to 10.41 percent in December 2025.
Vasa Denticity Ltd
Vasa Denticity Limited is in the business of marketing and distribution of a comprehensive portfolio of Dental Products with over 20,000 SKUs, across India. In the Q3FY26 result Vasa Denticity Ltd has seen its revenue from operations increase by 13 percent YoY, from Rs 63 Cr in Q3FY25 to Rs 71 Cr in Q3FY26, while the QoQ decreased by 3 percent from Rs 73 Cr. The net profits fell by 62 percent going from Rs 4 Cr in Q3FY25 to Rs 1.5 Cr in Q3FY26, while the QoQ also decreased by 70 percent from Q2FY26’s Rs 5 Cr.
As of December 2025, Mukul Agrawal, holds 4 lakh equity shares, equivalent to 2.4 percent in the company. While, the Foreign institutional investors (FIIs) have increased their stake by 3.5 percent in December 2025, rising from 4 percent in Sept 2025 to 7.5 percent in December 2025.
Zota Health Care Ltd
Zota Health Care Ltd is engaged in the manufacturing, marketing, and distribution of generic medicines. It focuses on branded generics, specialty formulations, and active pharmaceutical ingredients, serving domestic and export markets through a wide distribution network and strategic partnerships.
In the latest quarterly result the Zota Health Care Ltd has seen its revenue from operations increase by 99 percent YoY, from Rs 72 Cr in Q3FY25 to Rs 143 Cr in Q3FY26, while the QoQ increased by 11 percent from Rs 129 Cr. But, the company saw its net loss grow from Rs 19 Cr in Q3FY25 to Rs 30 Cr in Q3FY26.
As of December 2025, Mukul Agrawal, holds 25 lakh equity shares, equivalent to 7.5 percent in the company. While, the Foreign institutional investors (FIIs) have increased their stake by 4.5 percent in December 2025, rising from 3.5 percent in Sept 2025 to 8 percent in December 2025.
Radico Khaitan Ltd
Radico Khaitan Ltd,is one of India’s leading manufacturers of Indian Made Foreign Liquor (IMFL). Headquartered in New Delhi, the company produces whisky, rum, vodka, gin, and brandy, owning popular brands such as Magic Moments, 8 PM, Morpheus, and Contessa, with strong domestic and export presence.
In the latest quarterly result the Radico Khaitan Ltd has seen its revenue from operations increase by 19 percent YoY, from Rs 1,294 Cr in Q3FY25 to Rs 1,547 Cr in Q3FY26, while the QoQ increased by 3 percent from Rs 1,494 Cr. The net profits grew by 61 percent going from Rs 96 Cr in Q3FY25 to Rs 155 Cr in Q3FY26, while the QoQ increased by 11 percent from Q2FY26’s Rs 139 Cr.
As of December 2025, Mukul Agrawal, holds 14 lakh equity shares, equivalent to 1.1 percent in the company. The Foreign institutional investors (FIIs) have increased their stake by 1.82 percent in December 2025, rising from 18 percent in Sept 2025 to 19.82 percent in December 2025.
Strides Pharma Science Ltd
Strides Pharma Science Ltd, is engaged in the development and manufacturing of generic formulations. Headquartered in Bengaluru, it operates across regulated and emerging markets, focusing on complex generics, specialty products, and soft gelatin capsules, supported by multiple manufacturing facilities and international regulatory approvals.
In the latest quarterly result the Strides Pharma Science Ltd has seen its revenue from operations increase by 3 percent YoY, from Rs 1,154 Cr in Q3FY25 to Rs 1,195 Cr in Q3FY26, while the QoQ decreased by 2 percent from Rs 1,221 Cr. The net profits grew by 131 percent going from Rs 90 Cr in Q3FY25 to Rs 208 Cr in Q3FY26, while the QoQ increased by 57 percent from Q2FY26’s Rs 132 Cr.
As of December 2025, Mukul Agrawal, holds more than 10.5 lakh equity shares, equivalent to 1.2 percent in the company. While, the Foreign institutional investors (FIIs) have increased their stake by 1 percent in December 2025, rising from 28.5 percent in Sept 2025 to 29.5 percent in December 2025.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
